0000950142-05-000303.txt : 20120725
0000950142-05-000303.hdr.sgml : 20120725
20050208155849
ACCESSION NUMBER: 0000950142-05-000303
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20050208
DATE AS OF CHANGE: 20050208
GROUP MEMBERS: JEFFREY THORP
GROUP MEMBERS: LANGLEY CAPITAL, LLC
GROUP MEMBERS: LANGLEY MANAGEMENT, LLC
GROUP MEMBERS: LANGLEY PARTNERS, L.P.
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: NANOGEN INC
CENTRAL INDEX KEY: 0001030339
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 330489621
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-54207
FILM NUMBER: 05584063
BUSINESS ADDRESS:
STREET 1: 10398 PACIFIC CENTER COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858 410 4600
MAIL ADDRESS:
STREET 1: 10398 PACIFIC CENTER COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: LANGLEY PARTNERS LP
CENTRAL INDEX KEY: 0001142500
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 535 MADISON AVENUE
STREET 2: 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-850-7528
SC 13G/A
1
sc13ga2-nanogen.txt
AMENDMENT NO. 2
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Nanogen, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
630075109
(CUSIP Number)
December 31, 2004
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
2
CUSIP No. 630075109
1. Name of Reporting Person:
Langley Partners, L.P.
2. Check the Appropriate Box if a Member of a Group:
(a) [_]
(b) [X]
3. SEC Use Only
4. Citizenship or Place of Organization: Delaware
5. Sole Voting Power: -0-
Number of
Shares
Beneficially 6. Shared Voting Power: -0-
Owned By
Each
Reporting 7. Sole Dispositive Power: -0-
Person
With
8. Shared Dispositive Power: -0-
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
-0-
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:
[_]
11. Percent of Class Represented by Amount in Row (9): 0%
12. Type of Reporting Person: PN
3
CUSIP No. 630075109
1. Name of Reporting Person:
Langley Management, LLC
2. Check the Appropriate Box if a Member of a Group:
(a) [_]
(b) [X]
3. SEC Use Only
4. Citizenship or Place of Organization: Delaware
5. Sole Voting Power: -0-
Number of
Shares
Beneficially 6. Shared Voting Power: -0-
Owned By
Each
Reporting 7. Sole Dispositive Power: -0-
Person
With
8. Shared Dispositive Power: -0-
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
-0-
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:
[_]
11. Percent of Class Represented by Amount in Row (9): 0%
12. Type of Reporting Person: OO
4
CUSIP No. 630075109
1. Name of Reporting Person:
Langley Capital, LLC
2. Check the Appropriate Box if a Member of a Group:
(a) [_]
(b) [X]
3. SEC Use Only
4. Citizenship or Place of Organization: Delaware
5. Sole Voting Power: -0-
Number of
Shares
Beneficially 6. Shared Voting Power: -0-
Owned By
Each
Reporting 7. Sole Dispositive Power: -0-
Person
With
8. Shared Dispositive Power: -0-
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
-0-
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:
[_]
11. Percent of Class Represented by Amount in Row (9): 0%
12. Type of Reporting Person: OO
5
CUSIP No. 630075109
1. Name of Reporting Person:
Jeffrey Thorp
2. Check the Appropriate Box if a Member of a Group:
(a) [_]
(b) [X]
3. SEC Use Only
4. Citizenship or Place of Organization: United States
5. Sole Voting Power: -0-
Number of
Shares
Beneficially 6. Shared Voting Power: -0-
Owned By
Each
Reporting 7. Sole Dispositive Power: -0-
Person
With
8. Shared Dispositive Power: -0-
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
-0-
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:
[_]
11. Percent of Class Represented by Amount in Row (9): 0%
12. Type of Reporting Person: IN
6
This Amendment No. 2 to Schedule 13G is filed by the
undersigned to amend and restate in its entirety the Schedule 13G, dated
September 24, 2003, as amended by Amendment No. 1, dated January 30, 2004, with
respect to the shares of Common Stock, par value $0.001 per share, of Nanogen,
Inc.
Item 1(a). Name of Issuer:
Nanogen, Inc. (the "Company").
Item 1(b). Address of Issuer's Principal Executive Offices:
10398 Pacific Center Court
San Diego, CA 92121
Item 2(a). Name of Persons Filing:
(i) Langley Partners, L.P. ("Langley L.P."), (ii) Langley
Management, LLC, (iii) Langley Capital, LLC and (iv) Jeffrey
Thorp ("Thorp", together with Langley L.P., Langley
Management, LLC and Langley Capital, LLC, the "Reporting
Persons").
Item 2(b). Address of Principal Business Office:
For each Reporting Person:
535 Madison Avenue
7th Floor
New York, NY 10022.
Item 2(c). Citizenship:
See row 4 of each Reporting Persons' cover page.
Item 2(d). Title of Class of Securities:
Common Stock, $0.001 par value per share, of the Company
Item 2(e). CUSIP Number:
630075109
Item 3. Not applicable.
Item 4. Ownership.
For each Reporting Person:
(a) Amount beneficially owned:
7
-0- shares of Common Stock.
(b) Percent of class:
0% of the total outstanding shares of Common Stock.
(c) Number of shares to which each Reporting Person has:
(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: -0-
(iii) Sole power to dispose or to direct the
disposition of: -0-
(iv) Shared power to dispose of or direct the
disposition of: -0-
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported By the Parent Holding
Company.
Not Applicable.
Item 8. Identification and Classification of Members of the Group.
Not Applicable.
Item 9. Notice of Dissolution of a Group.
Not Applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
8
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 8, 2005
LANGLEY PARTNERS, L.P.
By: LANGLEY CAPITAL, LLC,
as General Partner
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
LANGLEY MANAGEMENT, LLC
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
LANGLEY CAPITAL, LLC
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
/s/ Jeffrey Thorp
--------------------------------------------
Jeffrey Thorp
EX-99
2
ex1_sc13ga2-nanogen.txt
EXHIBIT 1
10
EXHIBIT 1
---------
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of
1934, as amended, the undersigned agree to the joint filing on behalf of each of
them of a statement on Schedule 13G (including amendments thereto) with respect
to the Common Stock, par value $0.001 per share, of Nanogen, Inc., and further
agree that this Joint Filing Agreement shall be included as an exhibit to such
joint filings.
The undersigned further agree that each party hereto is responsible for
the timely filing of such Schedule 13G and any amendments thereto, and for the
completeness and accuracy of the information concerning such party contained
therein; provided, however, that no party is responsible for the completeness or
accuracy of the information concerning any other party making the filing, unless
such party knows or has reason to believe that such information is inaccurate.
IN WITNESS WHEREOF, the parties have executed this Joint Filing
Agreement on February 8, 2005.
LANGLEY PARTNERS, L.P.
By: LANGLEY CAPITAL, LLC,
as General Partner
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
LANGLEY MANAGEMENT, LLC
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
LANGLEY CAPITAL, LLC
By: /s/ Jeffrey Thorp
---------------------------------------
Jeffrey Thorp, Manager
/s/ Jeffrey Thorp
--------------------------------------------
Jeffrey Thorp